Similar articles

• European Society of Hypertension Working Group on Obesity: background, aims and perspectives.

  Jordan J, Engeli S, Redon J, Sharma AM, Luft FC, Narkiewicz K, Grassi G; European Society of Hypertension Working Group on Obesity. Jordan J, et al. J Hypertens. 2007 Apr;25(4):897-900. doi: 10.1097/HJH.0b013e328051b510. J Hypertens. 2007. PMID: 17351387 Review. No abstract available.
• Epidemiology of uncontrolled hypertension in the United States.

  Wang TJ, Vasan RS. Wang TJ, et al. Circulation. 2005 Sep 13;112(11):1651-62. doi: 10.1161/CIRCULATIONAHA.104.490599. Circulation. 2005. PMID: 16157784 Review. No abstract available.
• [Hypertension in obesity: its epidemiology, physiopathology and treatment efforts].

  Sharma AM, Moeller T, Engeli S. Sharma AM, et al. Dtsch Med Wochenschr. 1999 Nov 12;124(45):1337-41. doi: 10.1055/s-2007-1024539. Dtsch Med Wochenschr. 1999. PMID: 10592777 Review. German. No abstract available.
• Chronic kidney disease, hypertension and silent brain infarction.

  Yovchevski P, Goshev E, Kostov K. Yovchevski P, et al. Nephrol Dial Transplant. 2008 Dec;23(12):4083. doi: 10.1093/ndt/gfn535. Epub 2008 Sep 23. Nephrol Dial Transplant. 2008. PMID: 18812440 No abstract available.
• The double challenge of resistant hypertension and chronic kidney disease.

  Rossignol P, Massy ZA, Azizi M, Bakris G, Ritz E, Covic A, Goldsmith D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Ortiz A, Vanholder R, Wiecek A, Zoccali C, London GM, Stengel B, Fouque D; ERA-EDTA EURECA-m working group; Red de Investigación Renal (REDINREN) network; Cardiovascular and Renal Clinical Trialists (F-CRIN INI-CRCT) network. Rossignol P, et al. Lancet. 2015 Oct 17;386(10003):1588-98. doi: 10.1016/S0140-6736(15)00418-3. Lancet. 2015. PMID: 26530623 Review.